Home › Employers › Dana-Farber Cancer Institute › Advanced Clinical Fellow
Advanced Clinical Fellow at Dana-Farber Cancer Institute: H-1B salaries
9 labor condition applications for the job title Advanced Clinical Fellow at Dana-Farber Cancer Institute. Median offered base salary $104,500; middle half $101,450–$104,500.
Applications (LCAs)9
Median offered salary$104,500
Middle half of salaries$101,450–$104,500
10th–90th percentile$91,609–$104,650
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 3 | $104,500 |
| FY2024 | 3 | $104,500 |
| FY2025 | 1 | $104,500 |
| FY2026 | 1 | $104,500 |
Applications
| Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|
| $104,500–$109,000 | Boston, MA | Feb 3, 2026 | Jul 15, 2026 | Certified |
| $104,500–$109,000 | Boston, MA | Feb 2, 2026 | Jul 22, 2026 | Denied |
| $104,500 | Boston, MA | Jun 12, 2025 | Jul 1, 2025 | Certified |
| $104,500 | Boston, MA | Jan 9, 2024 | Mar 14, 2024 | Certified |
| $105,000 | Boston, MA | Jan 2, 2024 | Mar 14, 2024 | Certified |
| $92,299–$92,300 | Boston, MA | Dec 7, 2023 | Feb 26, 2024 | Certified |
| $104,500 | Boston, MA | Jul 12, 2023 | Jan 1, 2024 | Certified |
| $104,500 | Boston, MA | Jun 28, 2023 | Jul 1, 2023 | Certified |
| $90,000 | Boston, MA | Jun 12, 2023 | Jul 1, 2023 | Certified, then withdrawn |
Other jobs at Dana-Farber Cancer Institute
- Research Fellow$72,000
- Clinical Fellow$95,000
- Instructor (Scientist)$83,700
- Statistician$94,169
- Research Technician$50,000
- Scientist II$101,672
- Scientist$90,000
- Computational Biologist$81,272
- Sr. Research Technician$55,028
- Scientist I$89,685
- Instructor (Physician / Scientist)$209,000
- Instructor$92,754
- Genetic Counselor$90,000
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).